Comparison of Transversalis Fascia Plane Block and Erector Spinae Plane Blocks in Cesarean Section
Overview
- Phase
- Not Applicable
- Intervention
- Bupivacaine 0.25% Injectable Solution
- Conditions
- Pain
- Sponsor
- Erzurum Regional Training & Research Hospital
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- Opioid Consumption
- Status
- Not yet recruiting
- Last Updated
- 4 months ago
Overview
Brief Summary
Cesarean section is one of the most common major surgical procedures performed worldwide,, Post-cesarean analgesia should provide adequate pain control while allowing the mother to remain active to meet the needs of the baby. Insufficient analgesia after cesarean section may be associated with acute postoperative pain, chronic pain, higher opioid consumption, delayed functional capacity, and postpartum depression. Techniques such as neuraxial techniques, oral and intravenous agents, wound infiltration, and behavioral therapy can be used in the treatment of post-cesarean pain pain. In addition, Transversus abdominis plane block (TAP), Quadratus Lumborum block (QLB), Erector Spina block (ESP), Transversalis Fascia plane block (TFP) are used safely under ultrasound guidance. In this study, it was aimed primarily to examine the effects of TFP and ESP blocks on pain scores, and secondarily to evaluate analgesic consumption.
Investigators
Omer Doymus
Medical Doctor
Erzurum Regional Training & Research Hospital
Eligibility Criteria
Inclusion Criteria
- •Between 18-50 years
- •Cesarean Section
Exclusion Criteria
- •Cesarean Section under general anesthesia
- •emergency cases
- •those with a body mass index greater than 35 kg/m2
- •coagulopathy
- •local infection
Arms & Interventions
Group ESP
Ultrasound-guided erector spinae plane block with 20 ml %0.25 bupivacaine, per side
Intervention: Bupivacaine 0.25% Injectable Solution
Group TFP
Ultrasound-guided Transversalis Fascia Plane Block block with 20 ml %0.25 bupivacaine, per side
Intervention: Bupivacaine 0.25% Injectable Solution
Outcomes
Primary Outcomes
Opioid Consumption
Time Frame: Postoperative first 24 hours
Opioid consumption postroperative period
Secondary Outcomes
- Visual Analog Pain Score(Postoperative first 24 hours)